Evidence map›Paper›PMID 42871852›Full record

ReviewMedComm2026

Network Biology: Current Status, Applications, Challenges, and Future Prospects.

Xinmeng Li, Laizhong Zhang, Yawen Ding, Kai Li, Shiyuan Chang, Linsen Pei, Zhengwei Li, Zhenzhen Chen

Abstract readReview
In one paragraph

Review in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinmeng LiAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Laizhong ZhangAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Yawen DingAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Kai LiAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Shiyuan ChangAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Linsen PeiAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.
Zhengwei LiAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0009-0008-0823-4350
Zhenzhen ChenAging Decoding and Regeneration Institute, School of Life Sciences Zhengzhou University Zhengzhou China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Network biology provides a systems-level framework for understanding how interactions among molecular components, cells, microbial communities, tissues, and organs generate biological function and disease phenotypes. Recent advances in multiomics, single-cell and spatial profiling, network inference, organoid and organ-on-chip technologies, computational modeling, and artificial intelligence have shifted the field from static molecular maps toward dynamic, multiscale, and predictive network models. Major branches include molecular interaction networks, intracellular regulatory networks, single-cell and multicellular networks, microbial networks, disease networks, and interorgan interaction networks. Experimental and computational approaches are compared with respect to network reconstruction, causal validation, and cross-scale integration. Biomedical applications span disease classification, biomarker discovery, therapeutic-target identification, drug-response prediction, regenerative medicine, and precision healthcare. Particular emphasis is placed on interorgan interaction networks, in which carrier, route, range, timescale, recipient specificity, directionality, and feedback are treated as distinct mechanistic dimensions while mechanistic confidence is distinguished from translational maturity. Persistent challenges include incomplete context-specific network reconstruction, uncertain causal directionality, limited cross-scale integration, model interpretability, and insufficient clinical validation. Further progress will depend on integrating longitudinal and perturbation-resolved measurements with human-relevant experimental systems and multiscale computational models that quantify uncertainty and support prospective validation of patient-specific predictions.

Indexed as

interorgan interaction networksmicrobial networksmolecular interaction networksnetwork biologysingle‐cell networks

Identifiers

PMID42871852
PMCPMC13660718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.